277 related articles for article (PubMed ID: 10362017)
1. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
2. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
3. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
Ropiquet F; Giri D; Lamb DJ; Ittmann M
J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
[TBL] [Abstract][Full Text] [Related]
4. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
Wu X; Jin C; Wang F; Yu C; McKeehan WL
Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
[TBL] [Abstract][Full Text] [Related]
7. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
Ittman M; Mansukhani A
J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
9. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
10. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2000 Jul; 157(1):249-55. PubMed ID: 10880394
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
15. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis.
El Ramy R; Verot A; Mazaud S; Odet F; Magre S; Le Magueresse-Battistoni B
J Endocrinol; 2005 Oct; 187(1):135-47. PubMed ID: 16214949
[TBL] [Abstract][Full Text] [Related]
17. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR
J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]